These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35380642)

  • 61. Preventing deaths and injuries from house fires: a cost-benefit analysis of a community-based smoke alarm installation programme.
    Yellman MA; Peterson C; McCoy MA; Stephens-Stidham S; Caton E; Barnard JJ; Padgett TO; Florence C; Istre GR
    Inj Prev; 2018 Feb; 24(1):12-18. PubMed ID: 28183740
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Program Evaluation and Decision Analytic Modelling of Universal Suicide Prevention Training (safeTALK) in Secondary Schools.
    Kinchin I; Russell AMT; Petrie D; Mifsud A; Manning L; Doran CM
    Appl Health Econ Health Policy; 2020 Apr; 18(2):311-324. PubMed ID: 31410773
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a lifetime model.
    Millar JA; Millward MJ
    Pharmacoeconomics; 2007; 25(5):429-42. PubMed ID: 17488140
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty.
    Mather RC; Hug KT; Orlando LA; Watters TS; Koenig L; Nunley RM; Bolognesi MP
    BMC Musculoskelet Disord; 2014 Jan; 15():22. PubMed ID: 24438051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost-effectiveness models for dental caries prevention programmes among Chilean schoolchildren.
    Mariño R; Fajardo J; Morgan M
    Community Dent Health; 2012 Dec; 29(4):302-8. PubMed ID: 23488214
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exploring the Economic Benefits of Modafinil for Post-Stroke Fatigue in Australia: A Cost-Effectiveness Evaluation.
    Bajorek B; Gao L; Lillicrap T; Bivard A; Garcia-Esperon C; Parsons M; Spratt N; Holliday E; Levi C
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105213. PubMed ID: 33066879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness of community-based childhood obesity prevention interventions in Australia.
    Ananthapavan J; Nguyen PK; Bowe SJ; Sacks G; Mantilla Herrera AM; Swinburn B; Brown V; Sweeney R; Lal A; Strugnell C; Moodie M
    Int J Obes (Lond); 2019 May; 43(5):1102-1112. PubMed ID: 30926947
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Moving towards malaria elimination in southern Mozambique: Cost and cost-effectiveness of mass drug administration combined with intensified malaria control.
    Cirera L; Galatas B; Alonso S; Paaijmans K; Mamuquele M; Martí-Soler H; Guinovart C; Munguambe H; Luis F; Nhantumbo H; Montañà J; Bassat Q; Candrinho B; Rabinovich R; Macete E; Aide P; Alonso P; Saúte F; Sicuri E
    PLoS One; 2020; 15(7):e0235631. PubMed ID: 32628741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effectiveness of platform screen doors for the prevention of subway suicides in South Korea.
    Chung YW; Kang SJ; Matsubayashi T; Sawada Y; Ueda M
    J Affect Disord; 2016 Apr; 194():80-3. PubMed ID: 26803779
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Optimizing chronic disease management mega-analysis: economic evaluation.
    Path-Theta Collaboration
    Ont Health Technol Assess Ser; 2013; 13(13):1-148. PubMed ID: 24228076
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 73. National cost savings from an ambulatory program for low-risk febrile neutropenia patients in Australia.
    Tew M; Forster D; Teh BW; Dalziel K
    Aust Health Rev; 2019 Oct; 43(5):549-555. PubMed ID: 31526466
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
    Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
    Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
    Shangguan S; Mozaffarian D; Sy S; Lee Y; Liu J; Wilde PE; Sharkey AL; Dowling EA; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2021 Oct; 144(17):1362-1376. PubMed ID: 34445886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ending the HIV epidemic in the USA: an economic modelling study in six cities.
    Nosyk B; Zang X; Krebs E; Enns B; Min JE; Behrends CN; Del Rio C; Dombrowski JC; Feaster DJ; Golden M; Marshall BDL; Mehta SH; Metsch LR; Pandya A; Schackman BR; Shoptaw S; Strathdee SA;
    Lancet HIV; 2020 Jul; 7(7):e491-e503. PubMed ID: 32145760
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost-effectiveness of a helpline for suicide prevention.
    Pil L; Pauwels K; Muijzers E; Portzky G; Annemans L
    J Telemed Telecare; 2013 Jul; 19(5):273-81. PubMed ID: 24163237
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Are Office-Based Workplace Interventions Designed to Reduce Sitting Time Cost-Effective Primary Prevention Measures for Cardiovascular Disease? A Systematic Review and Modelled Economic Evaluation.
    Gao L; Nguyen P; Dunstan D; Moodie M
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30866495
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
    van Eekelen R; Eijkemans MJ; Mochtar M; Mol F; Mol BW; Groen H; van Wely M
    Hum Reprod; 2020 Sep; 35(9):2037-2046,. PubMed ID: 32876323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.